KIDRON NADAV 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-22 9:30 pm Purchase |
2024-03-06 | 13D | Oramed Pharmaceuticals Inc. ORMP |
KIDRON NADAV | 2,343,919 5.700% |
1,000,473 (+74.47%) |
Filing |
| 2021-09-02 4:49 pm Sale |
2021-08-19 | 13D | Oramed Pharmaceuticals Inc. ORMP |
KIDRON NADAV | 1,343,446 4.100% |
-1,288,614 (-48.96%) |
Filing |